Promus ELITE™
Everolimus-Eluting Platinum Chromium Coronary Stent System
PLATINUM Workhorse Trial
Study Objective
Evaluate the safety and effectiveness of the Promus PtCr EES Coronary Stent System* for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the Xience CoCr EES.
Study Design
Prospective, Randomized, Controlled, Non-inferiority, Multicenter
Numerically Lower Ischemia-Driven TLR Through 5 Years2
![Numerically Lower Ischemia-Driven TLR Through 5 Years](https://www.bostonscientific.com/en-EU/products/stents-coronary/promus-elite-permanent-polymer-stent/clinical-outcomes/_jcr_content/maincontent-par/image.img.tlr-chart.png)
Comparable Event Rates Through 5 Years2
![Numerically Lower Event Rate Through 5 Years](https://www.bostonscientific.com/en-EU/products/stents-coronary/promus-elite-permanent-polymer-stent/clinical-outcomes/_jcr_content/maincontent-par/image_0.img.5-year-event-rates.jpg)